Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes

[1]  G. Dorn,et al.  Cytoplasmic signaling pathways that regulate cardiac hypertrophy. , 2001, Annual review of physiology.

[2]  E. Olson,et al.  Decoding calcium signals involved in cardiac growth and function , 2000, Nature Medicine.

[3]  G. Schultz,et al.  Role for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction. , 2000, Circulation research.

[4]  L. Brunton,et al.  Characterization of G-protein signaling in ventricular myocytes from the adult mouse heart: differences from the rat. , 2000, Journal of molecular and cellular cardiology.

[5]  A. Clerk,et al.  Small guanine nucleotide-binding proteins and myocardial hypertrophy. , 2000, Circulation research.

[6]  K. Chien,et al.  Signaling pathways for cardiac hypertrophy and failure. , 1999, The New England journal of medicine.

[7]  S. Orkin,et al.  Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Dimitrios Georgakopoulos,et al.  The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an α-cardiac myosin heavy chain missense mutation , 1999, Nature Medicine.

[9]  Y. Yazaki,et al.  The molecular mechanism of cardiac hypertrophy and failure. , 1998, Annals of the New York Academy of Sciences.

[10]  G. Dorn,et al.  Gq signaling in cardiac adaptation and maladaptation. , 1999, Trends in cardiovascular medicine.

[11]  E. Neer,et al.  Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Melvin I. Simon,et al.  Embryonic cardiomyocyte hypoplasia and craniofacial defects in Gαq. Gα11‐mutant mice , 1998 .

[13]  H. Matsubara,et al.  Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice. , 1998, Circulation.

[14]  R. Lefkowitz,et al.  Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. , 1998, Science.

[15]  M. Zile,et al.  Pressure-overload hypertrophy is unabated in mice devoid of AT1A receptors. , 1998, American journal of physiology. Heart and circulatory physiology.

[16]  Stefan Offermanns,et al.  Defective platelet activation in Gαq-deficient mice , 1997, Nature.

[17]  G. Dorn,et al.  Transgenic Gαq overexpression induces cardiac contractile failure in mice , 1997 .

[18]  G. Barsh,et al.  Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Sadoshima,et al.  The cellular and molecular response of cardiac myocytes to mechanical stress. , 1997, Annual review of physiology.

[20]  F. Alt,et al.  Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Alexander,et al.  Angiotensin receptors and their therapeutic implications. , 1996, Annual review of pharmacology and toxicology.

[22]  R. Lefkowitz,et al.  Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[23]  F. Marumo,et al.  Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. , 1994, Circulation.

[24]  S. Chien,et al.  Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  D. Levy,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[26]  D E Manyari,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.